Leukemia
Showing 17–21 of 21 results
-
VANFLYTA (quizartinib)
Read more -
VENCLEXTA (venetoclax) tablets, for oral use. Initial U.S. Approval: 2016
Read more -
VYXEOS (daunorubicin and cytarabine) liposome for injection
Read more -
XOSPATA (gilteritinib) tablets, for oral use. Initial U.S. Approval: 2018
Read more -
ZYDELIG (idelalisib) tablets, for oral use. Initial U.S. Approval: 2014
Read more
